Table 1. Clinical and laboratory characteristics of different groups in human. Log10 transformed FINS, FPG, HOMA-IR, and TG were used for statistical analysis. Normally distributed data are mean±SD and analyzed by ANOVA. Nonnormally distributed parameters are median (interquartile range) and analyzed by Mann-Whitney U test. Group C, control group; group L, low-dose group (ethanol <15 g/d); group M, middle-dose group (ethanol 15–47.9 g/d); group H, high-dose group (ethanol ≥48 g/d); BMI, body mass index; WHR, waist-hip ratio; WHR of body fat (BF), ratio of waist fat to hip fat; PBF, percentage of body fat; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; FPG, fasting plasma glucose concentration; FINS, fasting insulin concentration; HOMA-IR, homeostatic model assessment of insulin resistance. ^bP<0.05, ^cP<0.01 vs group C. ^eP<0.05, ^fP<0.01 vs group L. ^hP<0.05, ⁱP<0.01 vs group M.

Characteristics	Group C n=55	Group L n=54	Group M n=54	Group H n=40
Age (year)	42.96±15.16	42.61±14.25	43.89±15.27	51.08±12.30cfh
BMI (kg/m2)	22.15 (20.79–24.10)	22.64 (21.13–24.23)	22.47 (21.59–23.65)	23.17 (20.99–23.84)
WHR	0.86 (0.84–0.89)	0.84 (0.82-0.88)	0.84 (0.82–0.88)	0.89 (0.85–0.91)cfi
WHR of BF	0.87 (0.84–0.90)	0.89 (0.86–0.92)	0.88 (0.85–0.91)	0.91 (0.90–0.94)cfi
Body fat (Kg)	12.43±4.08	14.16±3.85	13.63±4.26	15.71±4.04ch
PBF (%)	19.31±5.77	21.13±2.50	20.70±5.94	22.59±5.07c
TC (mmol/L)	4.92±0.93	4.83±0.92	5.12±1.02	5.25±0.81e
HDL-C (mmol/L)	1.44±0.24	1.50±0.30	1.51±0.34	1.60±0.44b
LDL-C (mmol/L)	2.72±0.67	2.30±0.78	2.98±0.76	2.99±0.63
TG (mmol/L)	1.12±0.57	1.12±0.44	1.27±0.64	1.68±1.45be
FPG (mmol/L)	4.92±0.47	4.99±0.44	5.10±0.53	5.39±0.55cfi
FINS (mU/L)	5.05±1.85	5.89±3.03	5.53±2.73	6.68±3.40b
HOMA-IR	1.11±0.41	1.32±0.71	1.26±0.64	1.60±0.85ceh
Chemerin (ng/mL)	14.67±7.02	16.10±7.71	16.70±7.07	20.66±7.18cfi